Track the TAKEDA PHARMACEUTICAL CO LTD share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €55.6bn. The latest transaction was disclosed on 3 September 2026 (Cession). Among the most active insiders: Plump Andrew Stewart. The full history is openly available.
55
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€11m
19 ops.
Sell Volume
48Σ signal
Buys n/a€11m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,212 of 29,062 companies
59.0
score / 100
Value
79
Quality
39
FCF yld·
Earn yld·
EV/EBITDA6.8x
ROE-2.3%
Gross mgn65%
Net mgn2.1%
Debt/EBITDA6.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Takeda Pharmaceutical Co Ltd es una compañía farmacéutica japonesa enfocada en la investigación y desarrollo de medicamentos innovadores. Se especializa en áreas terapéuticas como oncología, enfermedades raras y trastornos gastrointestinales.